Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant rats
- Styliani Goulopoulou(corresponding author),
- Camilla F. Wenceslau,
- Cameron G. McCarthy,
- Takayuki Matsumoto,
- R. Clinton Webb
- University of North Texas Health Science Center,
- Augusta University,
- Hoshi University,
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Bacterial infections increase risk for pregnancy complications, such as preeclampsia and preterm birth. Unmethylated CpG DNA sequences are present in bacterial DNA and have immunostimulatory effects. Maternal exposure to CpG DNA induces fetal demise and craniofacial malformations; however, the effects of CpG DNA on maternal cardiovascular health have not been examined. We tested the hypothesis that exposure to synthetic CpG oligonucleotides (ODNs) during gestation would increase blood pressure and cause vascular dysfunction in pregnant rats. Pregnant and nonpregnant female rats were treated with CpG ODN (ODN 2395) or saline (Veh) starting on gestational day 14 or corresponding day for the nonpregnant groups. Exposure to CpG ODN increased systolic blood pressure in pregnant (Veh: 121 ± 2 mmHg vs. ODN 2395: 134 ± 2 mmHg, P < 0.05) but not in nonpregnant rats (Veh: 111 ± 2 mmHg vs. ODN 2395: 108 ± 5 mmHg, P > 0.05). Mesenteric resistance arteries from pregnant CpG ODN-treated rats had increased contractile responses to U46619 [thromboxane A<sub>2</sub> (TxA<sub>2</sub>) mimetic] compared with arteries from vehicle-treated rats [E<sub>max</sub> (%KCl), Veh: 87 ± 4 vs. ODN 2395: 104 ± 4, P < 0.05]. Nitric oxide synthase (NOS) inhibition increased contractile responses to U46619, and CpG ODN treatment abolished this effect in arteries from pregnant ODN 2395-treated rats. CpG ODN potentiated the involvement of cyclooxygenase (COX) to U46619-induced contractions. In conclusion, exposure to CpG ODN during gestation induces maternal hypertension, augments resistance artery contraction, increases the involvement of COX-dependent mechanisms and reduces the contribution of NOS-dependent mechanisms to TxA<sub>2</sub>-induced contractions in mesenteric resistance arteries.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages H1015-H1025Journal (Volume, Issue Number)
American Journal of Physiology - Heart and Circulatory Physiology (Volume 310, Issue 8)Publication milestones
- Published - 04/2016
Publication status
Published - 04/2016
ISSN
0363-6135Publication IDs
- Scopus: 84983657326
- PubMed: 26873968
Publication metrics
Metrics
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
SciVal
FWCI
1.00
SciVal
Author count
5
SciVal
citations
12
SciVal
Paper percentile
76
PlumX, opens in new tab
Citation count
31
Captures
26
Funding Details
This work was supported by American Heart Association (AHA) Grants 13SDG17050056, 13PRE14080019, and 15GNT25700451, the Society of Women’s Health Research, and the National Council for Scientific and Technological Development (CNPq)-Brazil.
FundersFunding numbers
AHA
13SDG17050056, 15GNT25700451, 13PRE14080019
SWHR
-CNPq
-